LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Labetalol and hypoglycaemia unawareness: two case reports and considerations about its use as an antihypertensive drug for women with diabetes and pregnancy.

    Mateu-Salat, M / Corcoy, R

    Acta diabetologica

    2021  Volume 58, Issue 6, Page(s) 817–818

    Language English
    Publishing date 2021-02-27
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1097676-0
    ISSN 1432-5233 ; 0940-5429
    ISSN (online) 1432-5233
    ISSN 0940-5429
    DOI 10.1007/s00592-021-01688-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19.

    Mateu-Salat, M / Urgell, E / Chico, A

    Journal of endocrinological investigation

    2020  Volume 43, Issue 10, Page(s) 1527–1528

    MeSH term(s) Adrenergic beta-Antagonists/administration & dosage ; Antibodies/blood ; Antithyroid Agents/administration & dosage ; Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Female ; Graves Disease/blood ; Graves Disease/etiology ; Graves Disease/physiopathology ; Graves Disease/therapy ; Humans ; Lung/diagnostic imaging ; Methimazole/administration & dosage ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/etiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Propranolol/administration & dosage ; Receptors, Thyrotropin/immunology ; SARS-CoV-2 ; Thyroglobulin/immunology ; Thyroid Function Tests/methods ; Treatment Outcome ; Ultrasonography/methods
    Chemical Substances Adrenergic beta-Antagonists ; Antibodies ; Antithyroid Agents ; Receptors, Thyrotropin ; Methimazole (554Z48XN5E) ; Thyroglobulin (9010-34-8) ; Propranolol (9Y8NXQ24VQ)
    Keywords covid19
    Language English
    Publishing date 2020-07-19
    Publishing country Italy
    Document type Case Reports ; Letter
    ZDB-ID 432272-1
    ISSN 1720-8386 ; 0391-4097 ; 1121-1369
    ISSN (online) 1720-8386
    ISSN 0391-4097 ; 1121-1369
    DOI 10.1007/s40618-020-01366-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia.

    Mangas, Natalia / Mateu-Salat, Manel / Martínez, María José / López, Alicia / Pujol, Isabel / Martínez, Carmen / Corcoy, Rosa

    Hormones (Athens, Greece)

    2023  Volume 22, Issue 3, Page(s) 453–456

    Abstract: Fear of hypoglycemia and hyperglycemia can lead to inappropriate diabetes self-management and untoward health outcomes. We report two patients, representative of these opposite conditions, who benefited from hybrid closed-loop technology. In the patient ... ...

    Abstract Fear of hypoglycemia and hyperglycemia can lead to inappropriate diabetes self-management and untoward health outcomes. We report two patients, representative of these opposite conditions, who benefited from hybrid closed-loop technology. In the patient with fear of hypoglycemia, time in range improved from 26 to 56% and the patient did not present with severe hypoglycemia. Meanwhile, the patient with hyperglycemia aversiveness had a drastic reduction in time below range, from 19 to 4%. We conclude that hybrid closed-loop technology was an effective tool for improvement of glucose values in two patients with fear of hypoglycemia and hyperglycemia aversiveness, respectively.
    MeSH term(s) Humans ; Blood Glucose ; Blood Glucose Self-Monitoring ; Diabetes Mellitus, Type 1/drug therapy ; Fear ; Hyperglycemia/prevention & control ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Insulin Infusion Systems
    Chemical Substances Blood Glucose ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2023-05-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2075912-5
    ISSN 2520-8721 ; 1109-3099
    ISSN (online) 2520-8721
    ISSN 1109-3099
    DOI 10.1007/s42000-023-00451-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus.

    Xie, Xinglei / Liu, Jiaming / García-Patterson, Apolonia / Chico, Ana / Mateu-Salat, Manel / Amigó, Judit / Adelantado, Juan María / Corcoy, Rosa

    Acta diabetologica

    2023  Volume 60, Issue 5, Page(s) 621–629

    Abstract: Aims: We aimed to explore the relationship between gestational weight gain (GWG) after Institute of Medicine (IOM) and pregnancy outcomes in women with type 1 and type 2 diabetes.: Methods: Retrospective cohort study at a tertiary medical center ( ... ...

    Abstract Aims: We aimed to explore the relationship between gestational weight gain (GWG) after Institute of Medicine (IOM) and pregnancy outcomes in women with type 1 and type 2 diabetes.
    Methods: Retrospective cohort study at a tertiary medical center (1981-2011).
    Outcome variables: 2 maternal and 14 fetal. Main exposure variable: GWG according to IOM. We calculated crude and adjusted ORs as well as population attributable (PAF) and preventable fractions (PPF) for significant positive and negative associations, respectively.
    Results: We evaluated 633 pregnant women with type 1 or type 2 diabetes. GWG was insufficient (iGWG) in 16.7% and excessive (eGWG) in 50.7%. In the adjusted analysis, GWG according to IOM was significantly associated with maternal outcomes (pregnancy-induced hypertension and cesarean delivery) and four fetal outcomes (large-for-gestational age, macrosomia, small-for-gestational age and neonatal respiratory distress). The association with large-for-gestational age newborns was negative for iGWG (0.48, CI 95% 0.25-0.94) and positive for eGWG (1.76, CI 95% 1.18-2.63). In addition, iGWG was associated with a higher risk of small-for-gestational age newborns and respiratory distress and eGWG with a higher risk of pregnancy-induced hypertension, caesarean delivery and macrosomia. PAF and PPF ranged from the 20.4% PPF of iGWG for large-for-gestational age to 56.5% PAF of eGWG for macrosomia.
    Conclusion: In this cohort of women with type 1 or type 2 diabetes, inadequate GWG after IOM was associated with adverse pregnancy outcomes; associations were unfavorable for eGWG and mixed for iGWG. The attributable fractions were not moderate, pointing to the potential impact of modifying inadequate GWG.
    MeSH term(s) Pregnancy ; Female ; Infant, Newborn ; Humans ; Middle Aged ; Pregnancy Outcome/epidemiology ; Gestational Weight Gain ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Fetal Macrosomia/epidemiology ; Fetal Macrosomia/etiology ; Retrospective Studies ; Hypertension, Pregnancy-Induced ; Weight Gain ; Body Mass Index ; Diabetes, Gestational/epidemiology ; Pregnancy Complications/epidemiology
    Language English
    Publishing date 2023-01-27
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1097676-0
    ISSN 1432-5233 ; 0940-5429
    ISSN (online) 1432-5233
    ISSN 0940-5429
    DOI 10.1007/s00592-023-02031-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics.

    Xie, Xinglei / Liu, Jiaming / García-Patterson, Apolonia / Chico, Ana / Mateu-Salat, Manel / Amigó, Judit / Adelantado, Juan María / Corcoy, Rosa

    Hormones (Athens, Greece)

    2023  Volume 23, Issue 1, Page(s) 121–130

    Abstract: Purpose: To assess predictors of gestational weight gain (GWG), according to the Institute of Medicine (IOM) 2009, in women with type 1 and type 2 diabetes.: Methods: This was a retrospective cohort study conducted at a tertiary center. GWG based on ... ...

    Abstract Purpose: To assess predictors of gestational weight gain (GWG), according to the Institute of Medicine (IOM) 2009, in women with type 1 and type 2 diabetes.
    Methods: This was a retrospective cohort study conducted at a tertiary center. GWG based on the IOM was assessed both uncorrected and corrected for gestational age. General and diabetes-related clinical characteristics were analyzed as predictors.
    Results: We evaluated 633 pregnant women with type 1 and type 2 diabetes. GWG uncorrected for gestational age was inadequate (iGWG) in 20.4%, adequate in 37.1%, and excessive (eGWG) in 42.5% of the women. Predictors included general (height, prepregnancy body mass index category, and multiple pregnancy) and diabetes-related clinical characteristics. Neuropathy and follow-up length were associated with iGWG (odds ratio (OR) 3.00, 95% CI 1.22-7.37; OR 0.92, 95% CI 0.86-0.97, respectively), while pump use and third-trimester insulin dose were associated with eGWG (OR 1.68, 95% CI 1.07-2.66; OR 3.64, 95% CI 1.88-7.06, respectively). Independent predictors for corrected GWG and sensitivity analyses also included general and diabetes-related clinical characteristics.
    Conclusion: In this cohort of women with type 1 and type 2 diabetes, non-adequate GWG was common, mainly due to eGWG, and associated clinical characteristics were both general and diabetes-related. Current clinical care of these women during pregnancy may favor weight gain.
    MeSH term(s) Pregnancy ; Female ; Humans ; Gestational Weight Gain ; Diabetes, Gestational ; Diabetes Mellitus, Type 2 ; Retrospective Studies ; Weight Gain ; Body Mass Index ; Pregnancy Outcome
    Language English
    Publishing date 2023-10-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2075912-5
    ISSN 2520-8721 ; 1109-3099
    ISSN (online) 2520-8721
    ISSN 1109-3099
    DOI 10.1007/s42000-023-00497-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown.

    Mateu-Salat, M / Asla, Q / Chico, A / Martínez, M C / Martínez, M J / López, A / Pujol, I / Corcoy, R

    Acta diabetologica

    2022  Volume 59, Issue 7, Page(s) 977–979

    MeSH term(s) Blood Glucose ; Blood Glucose Self-Monitoring ; COVID-19/epidemiology ; COVID-19/prevention & control ; Communicable Disease Control ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/epidemiology ; Feasibility Studies ; Female ; Glucose ; Humans ; Pregnancy ; Pregnant Women
    Chemical Substances Blood Glucose ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-03-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1097676-0
    ISSN 1432-5233 ; 0940-5429
    ISSN (online) 1432-5233
    ISSN 0940-5429
    DOI 10.1007/s00592-022-01862-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes⋆.

    Mateu-Salat, Manuel / Moreno-Fernández, Jesús / Mangas, Natalia / Genua, Idoia / Martínez, María José / López, Alicia / González, Cintia / Chico, Ana

    Endocrinologia, diabetes y nutricion

    2022  Volume 69, Issue 5, Page(s) 316–321

    Abstract: The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the ... ...

    Abstract The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the usefulness of and the level of satisfaction with the recommendations given by the FG in a group of patients with type 1 diabetes (DM1) who were FSL users. It included 31 subjects (54% women; age 41 ± 15 years; DM duration 21 ± 14 years; 22 with FSL > 12 months) who were provided with the FG. They completed a questionnaire on decision-making depending on glucose trend in different situations (before and three months after using the FG), and a satisfaction questionnaire (ad hoc). Demographic, clinical and glycaemic control data were collected. The percentage of subjects who used glucose trend in decision-making after receiving the FG increased: for adjusting insulin (51 vs. 83; p = 0.016), action without insulin (51 vs. 90%; p = 0.001), and in special circumstances. The FG was evaluated as very useful (4.19/5). There were no significant changes in glycaemic control, although the percentage of data gathered increased significantly (89.07 vs. 94.46%; p = 0.042). In conclusion, the FG was evaluated well for managing glucose trends with FSL by the patients with DM1 analysed, increasing their use of trend in decision-making, with no changes in glycaemic control, but with more data gathered.
    MeSH term(s) Adult ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring ; Female ; Glucose ; Humans ; Insulin/therapeutic use ; Male ; Middle Aged ; Patient Satisfaction ; Personal Satisfaction
    Chemical Substances Blood Glucose ; Insulin ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-05-14
    Publishing country Spain
    Document type Journal Article
    ISSN 2530-0180
    ISSN (online) 2530-0180
    DOI 10.1016/j.endien.2022.03.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SARS-COV-2 as a trigger for autoimmune disease

    Mateu-Salat, M. / Urgell, E. / Chico, A.

    Journal of Endocrinological Investigation

    report of two cases of Graves’ disease after COVID-19

    2020  Volume 43, Issue 10, Page(s) 1527–1528

    Keywords Endocrinology, Diabetes and Metabolism ; Endocrinology ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 432272-1
    ISSN 1720-8386 ; 0391-4097 ; 1121-1369
    ISSN (online) 1720-8386
    ISSN 0391-4097 ; 1121-1369
    DOI 10.1007/s40618-020-01366-7
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes.

    Mateu-Salat, Manuel / Moreno-Fernández, Jesús / Mangas, Natalia / Genua, Idoia / Martínez, María José / López, Alicia / González, Cintia / Chico, Ana

    Endocrinologia, diabetes y nutricion

    2021  

    Abstract: The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the ... ...

    Title translation Evaluación de la utilidad y satisfacción con la guía de uso del sistema flash de monitorización de glucosa (FreeStyle Libre®) en pacientes con diabetes tipo 1.
    Abstract The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the usefulness of and the level of satisfaction with the recommendations given by the FG in a group of patients with type 1 diabetes (DM1) who were FSL users. It included 31 subjects (54% women; age 41±15 years; DM duration 21±14 years; 22 with FSL>12 months) who were provided with the FG. They completed a questionnaire on decision-making depending on glucose trend in different situations (before and three months after using the FG), and a satisfaction questionnaire (ad hoc). Demographic, clinical and glycaemic control data were collected. The percentage of subjects who used glucose trend in decision-making after receiving the FG increased: for adjusting insulin (51 vs. 83; P=.016), action without insulin (51 vs. 90%; P=.001), and in special circumstances. The FG was evaluated as very useful (4.19/5). There were no significant changes in glycaemic control, although the percentage of data gathered increased significantly (89.07 vs. 94.46%; P=.042). In conclusion, the FG was evaluated well for managing glucose trends with FSL by the patients with DM1 analysed, increasing their use of trend in decision-making, with no changes in glycaemic control, but with more data gathered.
    Language Spanish
    Publishing date 2021-08-24
    Publishing country Spain
    Document type Journal Article
    ISSN 2530-0180
    ISSN (online) 2530-0180
    DOI 10.1016/j.endinu.2021.04.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top